ARCHIVES

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

This article is from The Cancer Letter archive.

Vol. 16 No. 34 | September 7, 1990

Download PDF Visit The Full Archive

Related Articles

Report on Carcinogens: Advisors Recommend Tobacco, UV Light, Tamoxifen, For Report

November 7, 1997

Advocacy: NCCS, ASCO Petition FDA To Set Standards For Expanded Access Programs.

April 14, 2006

In Congress: specer, Harkin Pan re-Introduction Of Research Trust Fund

March 21, 1997

Tracors’ Prime Contract Includes $1 Million for Additional Tests

May 17, 1974

AACR Says 5 Percent Of Meeting Registrants Couldn’t Attend Due To Volcanic Ash In Europe

April 30, 2010

Workshop concludes HPV Vaccines Would Be Valuable, Feasible

April 8, 1988